Members directory | Become a member | My DCVMN

Contact us

News

March 14, 2024

DCVMN Joint Statement with IFPMA and Trade Associations on Biopharmaceutical Industry Commitments

DCVMN Advocacy developingcountries Statement WeConnectToProtect

December 15, 2023

Panacea Biotec launches EasyFourPol® in India and receives registration of Valganciclovir Powder for Oral Solution in Germany

Global Health Healthcare Milestones Vaccine Equity Vaccines & immunization Vacine Innovation WeConnectToProtect

November 28, 2023

The 2nd World Local Production Forum

November 28, 2023

Sustainable Action for Climate and Health

November 28, 2023

IIL launches measles, rubella vaccine for children

#VaccineAdvancements GlobalHealth SouthSouthPartnerships vaccinedevelopment

November 28, 2023

Two pharma cos set to begin 3rd phase of human trials for dengue vaccine

#VaccineAdvancements CollaborativeInnovation DCVMNpartnerships

September 3, 2023

Initiative Covid-19 Technology Access Pool (C-TAP)

COVID-19 DCVMN achievements Vaccines & immunization WHO

August 2, 2023

Global equity and timely access: COVID-19 & beyond 23rd DCVMN Annual General Meeting 2022 report

access DCVMN AGM developingcountries manufacturing sustainability vaccinedevelopment Vaccines

July 11, 2023

Microarray patches (MAPS) can revolutionize vaccine delivery in developing countries thanks to it being cost-effective, safe, easy to distribute and requiring less training to administer.

DCVMN achievements Vaccines & immunization

June 5, 2023

SK bioscience Receives Marketing Authorization of COVID-19 Vaccine from UK MHRA

COVID-19 DCVMN achievements Vaccines & immunization

May 17, 2023

DCVMN in BIO KOREA

DCVMN achievements Vaccines

May 10, 2023

DCVMN at the 17th World Congress on Public Health (WCPH)

World Congress on Public Health

Our sponsors

Our sponsors

Our sponsors

Our sponsors